key: cord-0923568-sfbghycl authors: Gangemi, A. J.; Gupta, R.; Fernandez-Romero, G.; Zhao, H.; Patel, M.; Chowdhury, J.; Zantah, M.; Zheng, M.; Abramian, O.; Codella, S.; Vien, L.; Dominguez-Castillo, E.; Buckey, T.; Earley, C.; Frankovich, J.; Jurkowski, M.; Jurkowski, Z.; O'Brien, J.; Guo, N.; Stanley, P.; Halsey, B.; Kahlon, J.; Kaur, N.; Prosniak, R.; Kumaran, M.; Dass, C.; Fleece, D.; Jacobs, M. R.; Criner, G. J.; Group, Temple University COVID-19 Research title: Utility of a Clinical Scoring System for Point of Care Triaging in COVID-19 Pneumonia date: 2021-03-02 journal: nan DOI: 10.1101/2021.02.26.21252256 sha: c9b92703006c1e497dcd105f8bc6d208d262dfdd doc_id: 923568 cord_uid: sfbghycl Background: Surges in COVID-19 disease cases can rapidly overwhelm healthcare resources; triaging to appropriate levels of care can assist in resource planning. At the beginning of the pandemic, we developed a simple triage tool, the Temple COVID-19 Pneumonia Triage Tool (TemCOV) based on a combination of clinical and radiographic features that are readily available on presentation to categorize and predict illness severity. Methods: We prospectively examined 579 sequential cases admitted to Temple University Hospital who were assigned severity categories on admission. Our primary outcome was to compare the performance of TemCOV in predicting patients who have the highest likely of admission to the ICU at 24 and at 72 hours to other standard triage tools: the National Early Warning System (NEWS), the Modified Early Warning System (MEWS) and the CURB65 score. Additional endpoints included need for invasive mechanical ventilation (IMV) within 72 hours, total hospital admission charges, and mortality. Results: 26% of patients fell within our highest risk Category 4 and were more likely to require ICU admission at 24 hours (OR 11.51) and 72 hours (OR 8.6). Additionally they had the highest likelihood of needing IMV (OR 29.47) and in-hospital mortality (OR 2.37). , TemCOV performed similar to MEWS in predicting ICU admission at 24 hours (receive operator characteristic (ROC) curve area under the curve (AUC) 0.77 vs. 0.74, p=0.21) but better than NEWS2 and CURB65 (ROC AUC 0.77 vs. 0.69 and 0.77 vs. 0.64, respectively, p<0.01). While all severity scores had a weak correlation to hospital charges, the TemCOV performed the best among all severity scores measured (r=0.18); median hospital charges for Category 4 patients was $170,468 ($96,972-$487,556). Conclusion: TemCOV is a simple triage score that can be used upon hospitalization in patients with COVID-19 that predicts the need for hospital resources such as ICU bed capacity, invasive mechanical ventilation and personnel staffing. Background: Surges in COVID-19 disease cases can rapidly overwhelm healthcare resources; triaging to appropriate levels of care can assist in resource planning. At the beginning of the pandemic, we developed a simple triage tool, the Temple COVID-19 Pneumonia Triage Tool (TemCOV) based on a combination of clinical and radiographic features that are readily available on presentation to categorize and predict illness severity. We prospectively examined 579 sequential cases admitted to Temple University Hospital who were assigned severity categories on admission. Our primary outcome was to compare the TemCOV is a simple triage score that can be used upon hospitalization in patients with COVID-19 that predicts the need for hospital resources such as ICU bed capacity, invasive mechanical ventilation and personnel staffing. The coronavirus disease 2019 (COVID-19) pandemic strains healthcare resources and requires measures to improve resource allocation. With the high virulence of SARS-CoV-2 and rapid surge of COVID-19, healthcare resources became easily overwhelmed necessitating transformation of existing personnel, resources and usable spaces into surge areas. 1 Capacity strain on a health system can lower the chances of ICU admission for both sepsis and respiratory failure independent of disease severity 2 ; therefore there is an urgent need to identify methods to track ventilator and advanced respiratory resource utilization in high COVID-19 surges times through a better triage system that can be applied at patient presentation. An example of this is the COVID-GRAM risk calculator developed in China through a nation-wide analysis of hospitalized patients with COVID-19 through logistic regression. 3 This calculator uses 10 characteristics of patients with COVID-19 to predict a composite endpoint of critical illness (ICU admission, mechanical ventilation, or death). 3 Limitations of this scoring system include its derivation and validation in a strictly Chinese patient population and reliance on retrospective chart review to identify predictors that are statistically important but might not be clinically meaningful. Given that few COVID-19 specific triaging scores have been developed, other traditional scoring systems have been suggested to be used to help predict hospitalization or clinical worsening in COVID-19 infection. The CURB65 was derived from a modified British Thoracic Society severity score initially as a means to identify mortality risk but later validated as a triage assessment tool. A CURB65 >3 has a 75% sensitivity and specificity for 30-day mortality, with high rate of mortality (22%). 4 The National Early Warning System by the Royal College of Physicians (NEWS2) can be used to monitor the appropriateness of triage decisions in the emergency room, with >7 typically necessitating ICU transfer. 5 The Modified Early Warning System (MEWS) uses vital sign and mental status assessment to predict those at risk for deterioration, with scores >5 associated with a 5.4-fold and 10.9-fold increased odds of death and ICU admission, respectively. 6 The Pneumonia Severity Index (PSI) can predict those at low risk who could be managed as outpatients at severity class 3 lobar ground glass involvement with central extension; grade 4 had diffuse infiltrates, both central and peripheral, with also suggestion of advanced lesions (i.e. crazy-paving pattern, dense consolidation). Our CT scoring system predated the categories proposed jointly by the Society of Thoracic Radiology, the American College of Radiology, and Radiological Society of North America that describes typical chest CT findings for COVID-19 related disease but not the severity of infiltrates. 8 The patient was assigned a severity category on a 0-4 scale based on the highest score among the 3 domains. During planning for anticipated triage needs, all admitted patients had CT evaluation of disease burden. Patients in the 0-1 category were usually recommended for discharge home in the absence of extenuating or psychosocial circumstances, category 2 were usually stable for the general medial ward, categories 3 and 4 were triaged to either a step down unit or ICU setting but could be triaged to lower acuity at the discretion of the admitting team. The primary endpoint was the ability of TemCOV to predict ICU admission by 24 and 72 hours using a score of 4 as a cutoff and compared it to the other scoring systems using previously defined cutoffs for high mortality risk and/or need for ICU evaluation (7 for NEWS2 5 , 5 for MEWS 6 , and 4 for CURB65 4 ). Because of low percentage patients with a CURB65 score of 4, the endpoint was instead assessed for scores >3. A NEWS2 cutoff of 7 has a much better sensitivity for predicting ICU admissions than the lower cutoff of 5 that typically triggers a rapid response assessment (98% vs. 69%). 9, 10 COVID-GRAM scores were calculated for patients when all variables were present, and patients were divided into the medium and high-risk groups based on the cutoff of 138.5 as determined by the prediction model. 3 These endpoints were chosen because of the need to quickly evaluate resource allocation in a pandemic setting. Our institution was not limited by ICU capabilities as we were able to convert a separate hospital building to provide dedicated COVID-19 ICUs, step-down units and general floor bed areas, with the capabilities to provide advanced oxygenation and hemodynamic support. Space limitations did not affect influence the decision to upgrade patients to a critical level of care. We additionally looked at the predictive value of each scoring system for need of invasive mechanical ventilation (IMV) by 24 hours, in-hospital mortality, total hospital admission charges, and number of patients requiring escalation in level of care by 72 hours. Supplementary Figure 1 displays graphically the timing of data collection, calculation of individual severity scores, and endpoints. Descriptive statistics are reported for the entire cohort. Additionally characteristics between survivors and non-survivors, critically ill vs. those managed on the medicine floor, and those mechanically ventilated vs. those managed with other forms of oxygenation support were compared using Student's t-test, Chi-Square, and Fisher Exact Test, where appropriate. The predictive value for each scoring system was compared using odds ratios (OR) and logistic regression at each of their respective cutoffs. Receiver-operator characteristic (ROC) curves for the primary endpoint were constructed for each scoring system and compared to the TemCOV. Hospital admission charges (in US Dollars, with interquartile range (IQR)) were compared between each severity category using Kruskal-Wallis Test for non-parametric data; for comparison between scoring systems, we converted total charges to log scale and compared Pearson's coefficients. The PSI and COVID-GRAM scores were assessed for patients when complete clinical data was available; therefore many patients were excluded and statistical comparisons were not performed given the reduction in power. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. For all comparisons, a p-value of <0.05 was considered significant. Statistical analyses were performed with the use of Stata 14.0 (StataCorp LP, College Station, TX). A total of 579 patients were included in the primary analysis; 68% percent were positive by RT-PCR. The majority (64.8%) fell into category 3 followed by category 4 (26.1%). Patients had an average age of 58.8+15.1 years, average BMI of 31.3+8kg/m 2 , and 42% were female. 89.1% had at least 1 comorbidity, the most frequently reported was hypertension (71.2%), followed by diabetes (44.7%) and psychiatric illness (21.5%); 47% were active or former smokers. 13.3% required some form of advanced respiratory therapy on admission (high flow nasal therapy (HFNT), non-invasive ventilation (NIV), or IMV). Vital sign trend within the first 24 hours and admission lab results are displayed in Table 2 . Overall mortality was 12.6%. The distribution of the TemCOV categories were as follows: (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; In addition to predicting overall hospital outcomes, TemCOV also stratified hospital admission charges. Category 4 scores were associated with median hospital charges of $170,468 (IQR $96,972-$487,556); this was $109,400 above those incurred by Category 2 patients and $66,000 above those with Category 3 scores (Kruskal-Wallis p<0.0001). Maximum hospital charges exceeded $4 million in Category 4 patients as $3.6 million for a Category 3 patient. Box-and-whisker plots for total admission hospital charges are presented in Figure 2A . hours. ROC curves with AUCs are displayed in Figure 2 . Additionally, the TemCOV was better than MEWS, NEWS2, and CURB65 at predicting need for IMV at 24 hours ( Figure 3 ). Numerically, higher risk patients using TemCOV were more likely to be transferred to a higher level of care within 72 hours after initial triage to a general medicine service compared to other those deemed higher risk based on the other triage risk calculators; however none of these comparisons reached statistical significance (Table 3 ). All severity scores had low but positive correlation between increasing severity measures and the log transformation of hospital admission charges. Of these, the TemCOV score had the highest numerically (r=0.18) and statistically greater than NEWS (r=0.032, p=0.002) but similar to the correlations for MEWS and CURB65 (r=0.17 and r=0.15, p>0.05 for both). Box and whisker plots for hospital charges among the different severity scores are presented in Figure 4 . Because of unavailability of arterial blood gases or direct bilirubin, the PSI and COVID-GRAM scores were only available in 57 (9.8%) and 87 (15%) patients, respectively, so could not be compared to the TemCOV and other triage tools; only exploratory results are presented here. Thirty-nine patients had a PSI score >4 (average score 118.12+39.7) with a mortality of 43.6% All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We have shown that a simple scoring system TemCOV can quickly and easily predict patients who would require higher level of care immediately upon admission for COVID-19 pneumonia. TemCOV is independent of comorbidities despite nearly 90% of our population having at least one baseline medical condition. TemCOV's ability to distinguish risk for in-hospital mortality was modest; our overall mortality was 12%, lower than initial reports from the COVID-19 pandemic 11, 12 and more in-line with recent estimates. 3, 13 Our score uses some clinical vital sign parameters that are incorporated within other scoring systems, such as the COVID-19 Severity Index, that use respiratory rate, pulse oximetry, and O2 flow rate to evaluate for 24-hour respiratory decompensation. 14 In contrast to this score, TemCOV included mechanical ventilation and pressor use to provide clear guidance for triage, plan staff coverage, and track resource utilization. However, the number of category 4 patients who required either of these interventions was low (11% and 3%, respectively); instead many more fell into the highest risk category based on CT appearance and our findings underscore the importance of radiographic disease burden and its value in prediction of hypoxemic respiratory failure. Prediction scores based on CT disease burden can discriminate between those that present with mild disease compared to those who could develop critical illness. 15 Semi-quantitative CT involvement and not individual CT features (such as consolidation or air bronchograms) have been selected through machine learning for use in predictive modeling, but CT appearance was ultimately not incorporated in Wu and colleague's risk calculator. 16 Category 4 severity was associated with an 11-fold increased risk for ICU transfer within 24 hours of admission and an 8-fold increased risk by 72 hours. Not only does this translate to patient outcomes but hospital resource utilization as demonstrated by the increase in hospital charges, a surrogate for staffing and equipment needs. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Traditional scores of severity of illness can predict in-hospital mortality for COVID-19 patients 10, 12, 13, 17, 18 although evidence is limited to single-center experience with small sample sizes and fewer provide validation in a US center. A previous study of 105 patients in China comparing MEWS with the Rapid Emergency Medicine Score, the optimal cutoff for MEWS was found to be 2 for mortality, albeit with the modest sensitivity and specificity (68% and 65%, respectively); 19 our present study found a higher mean MEWS score among survivors (4.6). Adding an age cutoff >65 years in this previous study only slightly improved its predictive value. 19 This discrepancy may be related to difference in time course of our data collection (we examined the first 24 hours of admission for MEWS calculation) and a higher comorbidity burden overall. The CURB65 has also been studied for its role in the care of patients with COVID-19 pneumonia. A single-center French study showed HR 4.18 of scores 3-5 in meeting the composite outcome (ICU need, high flow oxygen, noninvasive or invasive ventilation, death), but still 20% of patients with a CURB65 <2 met the primary endpoint including 9% mortality at 14 days. 20 A Turkish study comparing PSI to CURB65 showed superiority of the former in predicting 30-day mortality, but still excellent predictive value between both models (AUC for ROC 0.88 vs. 0.9). 13 The mortality with a CURB65 >2 was 30.5% compared to 2.7% with lower scores; likewise higher PSI risk categories had mortality upwards of 28-65%. 13 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. recently developed a statistical model for predicting death in COVID-19 that utilized procalcitonin, 12 which may not be widely or readily available in some institutions. Death was the outcome of interest in this study and occurred about 3 weeks into their disease course; 12 however progression to end-organ complications including respiratory failure, acute kidney injury, and sepsis developed much earlier (median 11-13 days) after symptoms onset. 12 Therefore, we focused on short-term endpoints to validate our scoring system to make TemCOV clinically useful for triage and resource management purposes upon admission. TemCOV scoring is simple to use and performed comparably against more cumbersome systems. While our scoring system did not include any typical inflammatory markers of COVID-19 related cytokine storm, we intended to create a triage tool that did not rely on specialized markers which may not be immediately available at all hospitals. There are conflicting results on the use of biomarkers in the current literature of COVID-19-specific triage tools with some studies failing to demonstrate improved prognostic accuracy using CRP or procalcitonin, 13, 14 while others incorporate such markers to increase predictive value. 16 We chose 72 hours for our primary outcome, which is within the timeframe tested by other triage protocols, because more long-term endpoints (i.e. ICU transfer by discharge, mortality) are markers of prognostication and not ICU resource needs on admission. Limitations of our study include the validation of scores in a single health care system. We also recognize that our score does not take into account baseline comorbidities which can play a major role in the clinical outcomes and has been advocated by joint task forces. 1 Some of our patients on high flow nasal cannula therapy were managed on the general medical floor, which may be atypical for some institutions, but the incidence of this was low overall (6%). TemCOV is a simple tool for triage immediately upon hospitalization in patients with COVID-19. It can be tabulated within hours of initial presentation and updated throughout a patient's hospital course and used to predict the need for hospitalization resources-ICU bed capacity, invasive mechanical ventilation and other forms of respiratory equipment and personnel staffing. Higher TemCOV scores should initiate prompt clinical response and consideration for more frequent monitoring. TemCOV needs to be validated by others and given its nonspecific scoring characteristics, can also be studied in other types of viral pneumonias. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 3 : Escalation in Care Rates Between Different Scoring Systems. Number (with percentage) of patients who were upgraded to ICU after initial triage to a general medicine floor based on estimated risk category (high versus low risk). Statistical comparison for each group is in comparison to TermCOV by Fisher Exact Test. Abbreviations: MEWS: Modified Early Warning Score, NEWS: National Early Warning Score, TemCOV: Temple COVID-19 Pneumonia Triage Tool All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 2, 2021. ; https://doi.org/10.1101/2021.02.26.21252256 doi: medRxiv preprint Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians Association of a Novel Index of Hospital Capacity Strain with Admission to Intensive Care Units Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Validation of a modified Early Warning Score in medical admissions A prediction rule to identify low-risk patients with community-acquired pneumonia Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA -Secondary Publication National Early Warning Score (NEWS) 2: Standardising the assessment of acuteillness severity in the NHS. Updated report of a working party Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19 Development and validation of the quick COVID-19 severity index (qCSI): a prognostic tool for early clinical decompensation Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiology: Cardiothoracic Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19 Clinical review: scoring systems in the critically ill Severity of illness scoring systems and performance appraisal How to derive and validate clinical prediction models for use in intensive care medicine The following are acknowledging for also contributing to data collection: Stephanie Jeong, MD. We would also like to acknowledge Abhi Rastogi, MBA, MIS and Christopher Snyder, MBA for assistance with compiling hospital charge data.